The Australian National Cervical Screening Program (NCSP) was established in 1991, and resulted in a halving in the incidence and mortality of cervical cancer by the early years of this century.1 This outstanding achievement was due to an organised approach to screening by the coordinated efforts ...
Cervical screening: time to change the policy. Med J Aust 2002; 176: 547- 550.Dickinson JA. Cervical screening: time to change the policy. Med J Aust. 2002 Jun 3;176(11):547-50. 117. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison ...
To estimate the rate of cervical cancer screening in Western Australia in 1992, and any variation by age, place of residence, and socio-economic status; and to determine the proportion of smears taken by different service providers. Descriptive study; collection of data from Papanicolaou (Pap) sm...
HPV screening every 5 years. Furthermore, VIA generated more than double the number of pre-cancer treatments compared to HPV. In conclusion, primary HPV screening is the most effective, cost-effective and efficient cervical screening option in LMICs. These findings have directly informed WHO’s ...
Dickinson, MBBS, PhD JAMA Comment & Response Age of Initiation of Cervical Cancer Screening—Reply Susan J. Curry, PhD; Alex H. Krist, MD, MPH; Douglas K. Owens, MD, MS JAMA JAMA Insights Cervical Cancer Screening: More Choices in 2019 George F. Sawaya, MD; Karen Smith-McCune, MD, ...
Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study BackgroundThere is little consensus, and minimal evidence, regarding the age at which to stop cervical screening. We studied the association between screen... ...
(Supplementary TableS2). Calculating the PPV for CIN2+ based on the first cytology test up to age ≤23 years gave the same results as the main analysis based on the first organised screening test at age 23 years (Supplementary TableS3). After applying a data truncation for all birth ...
Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia. BMC Cancer 2014;14:207 View Article PubMed/NCBI 22 Yuan Y, Cai X, Shen F, Ma F. HPV ...
445382 aged 30-44 at the time of the third negative smear test.10 year cumulative incidence of interval cervical cancer.105 women developed cervical cancer within 2595964 woman years at risk after the third negative result at age 30-44 and 42 within 1278532 woman years at risk after age 45-...
This paper summarises the position of ESGO and EFC on cervical screening based on existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as this offers greater protection against cervical cancer and allows longer screening intervals. Only a dozen of HPV tests...